Edesa Biotech, Inc. (EDSA)
USD 1.82
(-2.67%)
USD 1.82
(-2.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.63 Million | -12.27 Million | -13.66 Million | -4.98 Million | -4.84 Million | -4.61 Million |
| Net Income | -8.37 Million | -17.54 Million | -13.34 Million | -6.36 Million | -2.77 Million | -5.03 Million |
| Depreciation & Amortization | 183.47 Thousand | 118.18 Thousand | 118.78 Thousand | 57.56 Thousand | 4779.00 | 188.37 Thousand |
| Deferred income taxes | -308 Thousand | -2.37 Million | -3.31 Million | -655.92 Thousand | -2.76 Million | 55.29 Thousand |
| Stock-based compensation | 1.24 Million | 2.26 Million | 3.19 Million | 598.35 Thousand | 46.5 Thousand | 154.31 Thousand |
| Change in working capital | 308 Thousand | 2.89 Million | -3.63 Million | 721.96 Thousand | -2.1 Million | 13.04 Thousand |
| Other non-cash items | 308 Thousand | 2.37 Million | 3.31 Million | 655.92 Thousand | 2.76 Million | 12.41 Thousand |
| Investing Cash Flow | - | -5656.00 | -6146.00 | 19.07 Thousand | 6.41 Million | -4.46 Million |
| Investments in PPE | 3.00 | -5656.00 | -6146.00 | -34.33 Thousand | -8095.00 | -382.81 Thousand |
| Acquisitions | - | - | - | 29.48 Thousand | 6.38 Million | - |
| Investment purchases | - | - | - | -500 Thousand | - | -9.08 Million |
| Sales/Maturities of investments | - | - | - | 500 Thousand | - | 5 Million |
| Other Investing Activities | - | - | - | 23.92 Thousand | 36.74 Thousand | - |
| Financing Cash Flow | 4.83 Million | 11.62 Million | 14.17 Million | 7.09 Million | - | 8.77 Million |
| Debt repayment | - | - | - | -29.74 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.34 Million | 11.95 Million | 12.66 Million | 4.36 Million | - | 4.52 Million |
| Other Financing Activities | 485.09 Thousand | -328.05 Thousand | 1.51 Million | 2.76 Million | - | 4.25 Million |
| Accounts receivables | 562.77 Thousand | 2.02 Billion | -3.22 Million | 127.13 Thousand | 9737.00 | -40 Thousand |
| Accounts payables | -556.27 Thousand | 882.84 Thousand | -124.72 Thousand | 998.9 Thousand | -1.88 Million | 172.45 Thousand |
| Inventory | - | - | - | - | 77.91 Thousand | -156.15 Thousand |
| Other working capital | -6500.00 | -2.02 Billion | -281.36 Thousand | -404.06 Thousand | -313.63 Thousand | 209.19 Thousand |
| Cash at beginning of period | 7.09 Million | 7.83 Million | 7.21 Million | 5.03 Million | 3.36 Million | 4.57 Million |
| Cash at end of period | 5.36 Million | 7.09 Million | 7.83 Million | 7.21 Million | 5.03 Million | 4.22 Million |
| Capital Expenditure | 3.00 | -5656.00 | -6146.00 | -34.33 Thousand | -8095.00 | -382.81 Thousand |
| Effect of forex changes on cash | 76.85 Thousand | -93.01 Thousand | 121.9 Thousand | 57.63 Thousand | 91.3 Thousand | -35.65 Thousand |
| Net cash flow / Change in cash | -1.72 Million | -748.34 Thousand | 625.56 Thousand | 2.18 Million | 1.66 Million | -345.43 Thousand |
| Free Cash Flow | -6.63 Million | -12.28 Million | -13.67 Million | -5.02 Million | -4.85 Million | -4.99 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.66 Million | -1.86 Million | -1.67 Million | -8.37 Million | -1.72 Million | -1.98 Million |
| Depreciation & Amortization | 51.41 Thousand | 45.39 Thousand | 45.03 Thousand | 183.47 Thousand | 45.97 Thousand | 82.99 Thousand |
| Deferred income taxes | - | - | -3871.00 | -308 Thousand | 360.87 Thousand | -464.39 Thousand |
| Stock-based compensation | 109.5 Thousand | 100.00 | 184.36 | 1.24 Million | 517.08 | 110.00 |
| Change in working capital | 645.72 Thousand | 21.16 Thousand | 42.53 Thousand | 308 Thousand | -310.72 Thousand | -11.47 Thousand |
| Other non-cash items | -298.58 Thousand | 389.36 Thousand | 3871.00 | 308 Thousand | -360.87 Thousand | 464.39 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -3.66 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 99.27 Thousand | 214.29 Thousand | 305.74 Thousand | 4.83 Million | 412.46 Thousand | 741.23 Thousand |
| Debt repayment | -345.12 | -29.68 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 98.89 Thousand | 244 Thousand | 305.74 Thousand | 4.34 Million | 483.77 Thousand | 833.74 Thousand |
| Other Financing Activities | -32.36 Thousand | -34.56 Thousand | -9459.00 | 485.09 Thousand | -71.3 Thousand | -92.51 Thousand |
| Accounts receivables | 557.56 Thousand | -386.95 Thousand | -99.58 Thousand | 562.77 Thousand | -497.6 Thousand | 14.43 Thousand |
| Accounts payables | - | 207.61 Thousand | 103.45 Thousand | -556.27 Thousand | 378.98 Thousand | -223.71 Thousand |
| Inventory | - | - | - | - | -442.38 Thousand | -1656.00 |
| Other working capital | -130.24 Thousand | 200.49 Thousand | 38.66 Thousand | -6500.00 | 250.28 Thousand | 199.46 Thousand |
| Cash at beginning of period | 2.79 Million | 4.26 Million | 5.36 Million | 7.09 Million | 6.45 Million | 7.47 Million |
| Cash at end of period | 2.04 Million | 2.79 Million | 4.26 Million | 5.36 Million | 5.36 Million | 6.45 Million |
| Capital Expenditure | -3.66 | - | - | - | - | - |
| Effect of forex changes on cash | -8293.00 | -19.69 Thousand | 7176.00 | 76.85 Thousand | -40.21 Thousand | 49.9 Thousand |
| Net cash flow / Change in cash | -758.74 Thousand | -1.46 Million | -1.09 Million | -1.72 Million | -1.09 Million | -1.01 Million |
| Free Cash Flow | -814.92 Thousand | -1.67 Million | -1.4 Million | -6.63 Million | -1.46 Million | -1.8 Million |
GEV
002836
LNTO
2617
AVTNPL
2367